Skip to main content

Table 5 Pathways in MXSGD/model comparison group

From: Exploring the immune-inflammatory mechanism of Maxing Shigan Decoction in treating influenza virus A-induced pneumonia based on an integrated strategy of single-cell transcriptomics and systems biology

Pattern

Pathway

Counts

P-value

FDR

Compounds

POS

Primary bile acid biosynthesis

1

0.032463

1

25-Hydroxycholesterol cpd:C15519

NEG

Thiamine metabolism

1

0.024491

1

l-Cysteine cpd:C00097

 

Taurine and hypotaurine metabolism

1

0.027951

1

l-Cysteine cpd:C00097

 

Pantothenate and CoA biosynthesis

1

0.051892

1

l-Cysteine cpd:C00097

 

Glutathione metabolism

1

0.088558

1

l-Cysteine cpd:C00097

 

Cysteine and methionine metabolism

1

0.091834

1

l-Cysteine cpd:C00097

 

Glycine, serine and threonine metabolism

1

0.10485

1

l-Cysteine cpd:C00097

 

Primary bile acid biosynthesis

1

0.15231

1

Chenodeoxycholic acid cpd:C02528

 

Aminoacyl-tRNA biosynthesis

1

0.22117

1

l-Cysteine cpd:C00097